Cutaneous leishmaniasis in a Senegal patient;Leishmaniasis cutánea en paciente senegalés

Actas Dermo-Sifiliograficas

Volumn 98, Issue 1, 2007, Pages 54-58

  González Llavona, Beatriz ^a   Biosca Echenique, G ^b   Soto Diaz A ^a   Naranjo Diaz M J ^a   Espadafor Lopez B ^c   Garcia Mellado V ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c NONE

Author keywords

Cutaneous leishmaniasis; Leishmania infantum; Leishmania major; Senegal

Indexed keywords

MEGLUMINE ANTIMONATE;

ADULT; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CLINICAL EVALUATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; MALE; MYCOSIS; PATHOGENESIS; PHYSICAL EXAMINATION; PUNCH BIOPSY; SENEGAL; SKIN DEFECT; SKIN LEISHMANIASIS; TREATMENT OUTCOME;

EID: 33947417759     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(07)70011-X     Document Type: Article

References (17)

1. WHO Report on Global Surveillance of Epidemic- prone Infectious Diseases. WHO/CDS/CSR/ISR/2000.
2. García-Almagro D. Leishmaniasis cutánea. Actas Dermosifiliogr. 2005;96:1-24.
3. Sagüeza OP. Leishmaniasis. En: Bolognia JL, Jorizzo JL, Rapini R, editores. Dermatología. Madrid: Elsevier; 2004. p. 1.295-300.
4. Martín Sánchez J, Gramiccia M, Di Muccio T, Ludovisi A, Morillas-Marquez F. Isoenzymatic polymorphism of Leishmania infantum in southern Spain. Trans R Soc Trop Med Hyg. 2004;98:228-32.
5. Dedet JP, Safjanova JM, Le Blancq SM, Desjeux P. Caracterisation de souches de Leishmania major isolees au Senegal (Afrique de l'Ouest). En: Rioux JA, editor. Leishmania: Taxonomie et Phylogenèse. Montpellier: Applications Ecoépidémiologiques. IMEEE; 1986. p. 463-69.
6. Dedet JP, Derouin F, Hubert B, Schnur LF, Chance ML. Isolation of Leishmania major from Mastomys erythroleucus and Tateragambiana in Senegal (West Africa). An Trop Med Parasitol. 1979;73:433-7.
7. Zijlstra E. Leishmaniasis. En: Parry E, Godfrey R, Mabey D, Gill G, editors. Principles of Medicine in Africa. Cambridge: Cambridge University Press; 2004. p. 456-74.
8. García Almagro D. Leishmaniasis cutánea. En: España Alonso A, editor. Fisiopatología de las enfermedades cutaneas IV. Madrid: Aula Médica; 2004.
9. Lariviere M. Aspects cliniques et epidemiologiques de la leishmaniose cutanée au Senegal. Bull Soc Pathol Exot Filiales. 1966;59: 83-98.
10. Belazzoug S, Ammar-Khodja A, Belkaid M, Tabet-Derraz O. La Leishmaniose cutanee du nord d'Algerie. Bull Soc Pathol Exot. 1985;78:615-22.
11. Develoux M, Diallo S, Dieng Y, Mane I, Huerre M, Pradong F, et al. Diffuse cutaneous leishmaniasis due to Leishmania major in Senegal. Trans R Soc Trop Med Hyg. 1996;90: 396-7.
12. Gaafar A, Ismail A, el Kadaro AY, Hashim E, Khalil EA, el Hassan AM. Necrotizing and suppurative lymphadenitis in Leishmania major infections. Trop Med Int Health. 1996; 1:243-50.
13. Shazad B, Abbaszadeh B, Khamesipour A. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major. Eur J Dermatol. 2005;15:85-7.
14. Leishmaniasis tratadas con imiquimod. Actas Dermosifiliogr. 2003;94 Supl 1:61-2.
15. Alcalde M, Delgado V, Gutiérrez MT, et al. Leishmaniasis cutáneas: altemativas terapeuticas al glucantime. Actas Dermosifiliogr. 1989; 80:259-66.
16. El On J, Halevy S, Grunwald M, Weinrauch L. Topical Treatment of Old World Cutaneous leishmaniasis caused by Leishmania major: a double blind control study. J Am Acad Dermatol. 1992;27:27-31.
17. Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med. 2002;346:891-5.